387 related articles for article (PubMed ID: 16978602)
1. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
van Albada ME; Berger RM; Niggebrugge M; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG
Eur J Pharmacol; 2006 Nov; 549(1-3):107-16. PubMed ID: 16978602
[TBL] [Abstract][Full Text] [Related]
2. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
4. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.
Shen L; Shen J; Pu J; He B
Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
6. Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.
van Albada ME; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG; Berger RM
J Cardiovasc Pharmacol; 2006 Nov; 48(5):249-54. PubMed ID: 17110807
[TBL] [Abstract][Full Text] [Related]
7. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
[TBL] [Abstract][Full Text] [Related]
8. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
9. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
Zeng Z; Li Y; Jiang Z; Wang C; Li B; Jiang W
Cardiovasc Ther; 2010; 28(1):23-9. PubMed ID: 20074256
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic unloading leads to regression of pulmonary vascular disease in rats.
O'Blenes SB; Fischer S; McIntyre B; Keshavjee S; Rabinovitch M
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):279-89. PubMed ID: 11174733
[TBL] [Abstract][Full Text] [Related]
11. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat.
Kawaguchi AT; Kawashima Y; Ishibashi-Ueda H; Mizuta T; Kitoh Y; Kunieda T
J Heart Lung Transplant; 1993; 12(2):325-8; discussion 328-9. PubMed ID: 8476905
[TBL] [Abstract][Full Text] [Related]
12. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
14. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
15. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
Kramm T; Eberle B; Guth S; Mayer E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
[TBL] [Abstract][Full Text] [Related]
16. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
Mitani Y; Maruyama K; Sakurai M
Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
[TBL] [Abstract][Full Text] [Related]
17. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats].
Jin HF; Liang C; Liang JM; Tang CS; DU JB
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2235-9. PubMed ID: 19087668
[TBL] [Abstract][Full Text] [Related]
18. Effects of erythropoietin on advanced pulmonary vascular remodelling.
van Albada ME; du Marchie Sarvaas GJ; Koster J; Houwertjes MC; Berger RM; Schoemaker RG
Eur Respir J; 2008 Jan; 31(1):126-34. PubMed ID: 17898019
[TBL] [Abstract][Full Text] [Related]
19. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
20. Reversal of experimental pulmonary hypertension by PDGF inhibition.
Schermuly RT; Dony E; Ghofrani HA; Pullamsetti S; Savai R; Roth M; Sydykov A; Lai YJ; Weissmann N; Seeger W; Grimminger F
J Clin Invest; 2005 Oct; 115(10):2811-21. PubMed ID: 16200212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
